Citations |
1. McGovern NN, Cowburn AS, Porter L, Walmsley SR, Thompson AAR, et al. Hypoxia Selectively Inhibits Respiratory Burst Activity and Killing of Staphylococcus aureus in Human Neutrophils. J Immunol. 2011,186:453–463.<br />2. De Boeck A., et al. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics. 2013 Jan,13(2):379-88. doi: 10.1002/pmic.201200179. Epub 2013 Jan 6.<br />3. Farahi N,Cowburn A S,Upton P D, Deighton J, Sobolewski A,et al.Eotaxin-1/CC Chemokine Ligand 11: A Novel Eosinophil Survival Factor Secreted by Human Pulmonary Artery Endothelial Cells. J Immunol. 2007,179:1264–1273<br />4. Sze S, Kleijn D, Lai R, Tan E, Zhao H,et al.Elucidating the Secretion Proteome of Human Embryonic Stem Cell-derived Mesenchymal Stem Cells.Mol Cell Proteomics. 2007, 6: 1680-1693<br />5. Xu Y, Ganem D. Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Gen Virol. 2007,88:45-50.<br />6. Durand S H, Flacher V, Romeas A, Carrouel F,Colomb E,et al.Lipoteichoic Acid Increases TLR and Functional Chemokine Expression while Reducing Dentin Formation in In Vitro Differentiated Human Odontoblasts.J Immunol, 2006, 176: 2880-2887<br />7. Bingera T, Sticha S, Andreasa K, Kapsb C, Sezerc O,et al. Migration potential and gene expression profile of human mesenchymal stem cells induced by CCL25. Exp Cell Res. 2009,315:1468-1479 <br />8. Hsu M, Wu S, Chang S, Su I, Tsai C,et al.Epstein-Barr Virus Lytic Transactivator Zta Enhances Chemotactic Activity through Induction of Interleukin-8 in Nasopharyngeal Carcinoma Cells. J. Virol. April 2008 vol. 82 no. 7 3679-3688 <br />9. Rizzo M., et al. Low Molecular Weight Hyaluronan-Pulsed Human Dendritic Cells Showed Increased Migration Capacity and Induced Resistance to Tumor Chemoattraction. PLOS One, Published: September 19, 2014. DOI: 10.1371/journal.pone.0107944 |
Targets Detected |
BLC, CCL1, CCL11, CCL13, CCL15, CCL16, CCL17, CCL18, CCL19, CCL2, CCL20, CCL22, CCL23, CCL24, CCL25, CCL26, CCL27, CCL28, CCL3, CCL4, CCL5, CCL7, CCL8, CK beta 8-1, CTACK, CX3CL1, CXCL1, CXCL10, CXCL11, CXCL12 alpha, CXCL12 beta, CXCL13, CXCL16, CXCL5, CXCL6, CXCL7, CXCL8, CXCL9, ENA-78, Eotaxin-1, Eotaxin-2, Eotaxin-3, Fractalkine, GCP-2, GRO, GRO alpha, HCC-4, I-309, I-TAC, IL-8, IP-10, Lymphotactin, MARC, MCP-1, MCP-2, MCP-3, MCP-4, MDC, MEC, MIG, MIP-1 alpha, MIP-1 beta, MIP-1 delta, MIP-3 alpha, MIP-3 beta, MPIF-1, MPIF-2, NAP-2, PARC, PPBP, RANTES, SDF-1 alpha, SDF-1 beta, TARC, TCA-3, TCK-1, TECK, XCL1 |